These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23403704)

  • 1. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications.
    Bardini G; Rotella CM; Giannini S
    Rev Diabet Stud; 2012; 9(2-3):82-93. PubMed ID: 23403704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride is independently correlated with insulin resistance and islet beta cell function: a study in population with different glucose and lipid metabolism states.
    Ma M; Liu H; Yu J; He S; Li P; Ma C; Zhang H; Xu L; Ping F; Li W; Sun Q; Li Y
    Lipids Health Dis; 2020 Jun; 19(1):121. PubMed ID: 32487177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol metabolism and pancreatic beta-cell function.
    Fryirs M; Barter PJ; Rye KA
    Curr Opin Lipidol; 2009 Jun; 20(3):159-64. PubMed ID: 19417651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.
    Kim KS; Oh DH; Kim JY; Lee BG; You JS; Chang KJ; Chung HJ; Yoo MC; Yang HI; Kang JH; Hwang YC; Ahn KJ; Chung HY; Jeong IK
    Exp Mol Med; 2012 Nov; 44(11):665-73. PubMed ID: 23114424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GLP-1 based therapies on diabetic dyslipidemia.
    Patel VJ; Joharapurkar AA; Shah GB; Jain MR
    Curr Diabetes Rev; 2014; 10(4):238-50. PubMed ID: 24998439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of diabetic dyslipoproteinemia.
    Steinmetz A
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia.
    Nandeesha H; Koner BC; Dorairajan LN; Sen SK
    Clin Chim Acta; 2006 Aug; 370(1-2):89-93. PubMed ID: 16516184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
    Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
    Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats.
    Sakata S; Ito M; Mera Y; Sasase T; Yamamoto H; Kakutani M; Ohta T
    J Diabetes Res; 2014; 2014():803832. PubMed ID: 24895641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia.
    Ghani RA; Bin Yaakob I; Wahab NA; Zainudin S; Mustafa N; Sukor N; Wan Mohamud WN; Kadir KA; Kamaruddin NA
    J Clin Lipidol; 2013; 7(5):446-53. PubMed ID: 24079286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles.
    Ståhlman M; Fagerberg B; Adiels M; Ekroos K; Chapman JM; Kontush A; Borén J
    Biochim Biophys Acta; 2013 Nov; 1831(11):1609-17. PubMed ID: 23896361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.
    Keating GM
    Am J Cardiovasc Drugs; 2011 Aug; 11(4):227-47. PubMed ID: 21675801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylglyoxal treatment in lactating mothers leads to type 2 diabetes phenotype in male rat offspring at adulthood.
    Francisco FA; Barella LF; Silveira SDS; Saavedra LPJ; Prates KV; Alves VS; Franco CCDS; Miranda RA; Ribeiro TA; Tófolo LP; Malta A; Vieira E; Palma-Rigo K; Pavanello A; Martins IP; Moreira VM; de Oliveira JC; Mathias PCF; Gomes RM
    Eur J Nutr; 2018 Mar; 57(2):477-486. PubMed ID: 27752755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of lipid profiles with insulin resistance and β cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation.
    Zheng S; Xu H; Zhou H; Ren X; Han T; Chen Y; Qiu H; Wu P; Zheng J; Wang L; Liu W; Hu Y
    PLoS One; 2017; 12(2):e0172221. PubMed ID: 28199386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.